Biobank Equipment Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 2.9 billion
Estimated Base Value
2035 Forecast
US$ 11.3 billion
Projected Market Value
CAGR 2026–2035
14.6%
Compound Annual Growth
Largest Segment
Cryogenic Storage Systems
Fastest Growing Segment
Ultra-Low Temperature Freezers
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
25.5% market share
Key Players
PHC Holdings Corporation
Emerging Players
NuAire, Vestfrost Solutions
Market Definition & Overview
The Biobank Equipment Market comprises specialized medical devices, instruments, and integrated systems essential for the collection, processing, preservation, storage, and retrieval of biological samples (e.g., tissues, blood, DNA, cells) within biobanks, research institutions, and pharmaceutical companies. This market primarily focuses on cryogenic storage solutions designed to maintain the viability and integrity of these samples over extended periods. It encompasses equipment crucial for long-term bio-preservation, automation in sample handling, precise temperature control, and robust inventory management, supporting advancements in drug discovery, genomics, personalized medicine, and clinical research by ensuring the quality and accessibility of valuable biological assets.
Scope
- Global geographic market coverage.
- Biobank equipment utilized across academic, commercial, and disease-specific biobanks.
- Market analysis covering equipment sales and adoption within a defined forecast period.
Inclusions
- Cryogenic storage tanks (e.g., liquid nitrogen freezers) and ultra-low temperature freezers.
- Automated sample management systems and robotic biobanking platforms.
- Cryogenic vials, tubes, boxes, and racks designed for long-term storage.
- Temperature monitoring, data logging, and alarming systems for cryogenic environments.
- Sample identification, labeling, and barcoding solutions specific to biobanking.
- Biobank-specific inventory management and LIMS software.
Exclusions
- General laboratory equipment not specific to cryogenic sample storage or biobanking.
- Reagents, kits, and consumables for sample extraction or analysis.
- Non-cryogenic refrigeration or standard cold storage units.
- Transportation and logistics services for biological samples outside biobank facilities.
- Diagnostic instruments or general medical devices unrelated to biobank operations.
Market Size Forecast
Executive Summary
• The Biobank Equipment market is valued at $2.9 Bn in 2025 and is forecast to reach $11.3 Bn by 2035, reflecting a robust CAGR of 14.6% as demand accelerates across every major segment and region over the ten-year outlook.
• Cryogenic Storage Systems leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 42.1%, while Emerging Areas is expanding the fastest at a 8.5% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 25.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• The surge in personalized medicine initiatives and cell and gene therapy research is profoundly accelerating demand for advanced cryogenic storage solutions, driving innovation across global biobanking infrastructure and specialized equipment segments.
• Market consolidation driven by M&A activities among key players signals a strategic shift towards integrated cold chain solutions and comprehensive service offerings, intensifying competitive pressures, especially in high-growth Asia-Pacific regions.
• Stringent regulatory frameworks for sample integrity and traceability are propelling significant investments in automated, smart cryogenic systems and advanced inventory management software, ensuring long-term sample viability and compliance.
• Emerging economies, particularly in APAC and LATAM, represent critical growth frontiers due to increasing government funding for biomedical research and expanding healthcare infrastructure, creating distinct regional equipment demands.
• Investment trends reveal a strong focus on sustainable and energy-efficient cryogenic technologies, alongside resilient supply chain diversification, to mitigate geopolitical risks and optimize operational costs for biobanks globally.
• Future market expansion hinges on seamless integration of AI-driven analytics for predictive maintenance and enhanced sample utilization, further solidifying the industry's indispensable role in global biomedical research advancements.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Valuation
The Biobank Equipment Market was valued at $2.9 billion in the base year, underscoring its significant role in medical research and biotechnology.
Future Market Projection
The market is projected to achieve a valuation of $11.3 billion by the forecast year, indicating substantial growth and expanding demand for specialized equipment.
Robust Growth Outlook
Demonstrating a strong compound annual growth rate (CAGR) of 14.6%, the market is set for rapid expansion driven by increasing biobanking initiatives and research funding.
Cryogenic Storage Lead
Cryogenic storage equipment is expected to remain a leading segment, essential for the long-term preservation of biological samples vital for research and therapeutic development.
North American Dominance
North America is anticipated to lead the market, supported by advanced healthcare infrastructure, significant R&D investments, and a high concentration of biobanking facilities.
Automation Integration Trend
A notable trend is the increasing adoption of automation and robotics in biobanks, enhancing efficiency, sample integrity, and operational scalability across facilities.
Market Dynamics
Market Trends
- Increased automation in sample processing and storage.
- Growing demand for integrated digital data management systems.
- Focus on sustainable and energy-efficient cryogenic solutions.
- Rising adoption of remote monitoring and IoT in biobanks.
Growth Drivers
- Rising demand for biobanks in personalized medicine and research.
- Increasing prevalence of chronic diseases needing sample collection.
- Technological advancements in cryogenic storage solutions.
- Growing government and private funding for biomedical research.
Restraints
- High initial capital investment for specialized cryogenic equipment.
- Stringent regulatory hurdles increase development and compliance costs.
- Requirement for highly skilled personnel and specialized maintenance expertise.
- Risk of sample degradation or loss due to equipment malfunction or power outages.
Opportunities
- Expansion into emerging economies with growing healthcare infrastructure.
- Developing specialized and customized cryogenic storage solutions.
- Integrating AI and machine learning for enhanced biobank management.
- Growth in the market for related cryogenic consumables and services.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Cryogenic Storage SystemsAutomated Biobanking SystemsUltra-Low Temperature FreezersSample Handling & Processing EquipmentTemperature Monitoring & Alarm SystemsCryogenic Vials, Tubes & BoxesControlled Rate FreezersCold Chain Logistics & Transport Equipment |
| By Application | Biomedical ResearchDrug Discovery & DevelopmentPersonalized MedicineRegenerative MedicineGenomics & ProteomicsClinical TrialsDisease DiagnosticsVeterinary Biobanking |
| By End-User | Academic & Research InstitutionsPharmaceutical & Biotechnology CompaniesHospitals & Healthcare ProvidersContract Research OrganizationsDiagnostic LaboratoriesGovernment Agencies & Public BiobanksCord Blood & Stem Cell BanksForensic Laboratories |
| By Technology | Mechanical RefrigerationLiquid Nitrogen Immersion FreezingLiquid Nitrogen Vapor Phase FreezingRobotic AutomationBarcode & Radio Frequency IdentificationSensor Based Monitoring & ControlControlled Rate Freezing TechnologyArtificial Intelligence & Machine Learning |
| By Functionality | Sample Storage & PreservationAutomated Sample Retrieval & PlacementTemperature & Environment MonitoringSample Tracking & Inventory ManagementControlled Rate Freezing & ThawingSample Preparation & ProcessingQuality Control & AssuranceData Integration & Management |
| By Capacity | Small CapacityMedium CapacityLarge CapacityVery Large Capacity |
Regional Analysis
- North America leads the biobank equipment market, driven by its robust healthcare infrastructure and substantial research and development funding. High adoption of advanced technologies and a strong presence of major biobanking companies in the region further solidify its dominant position.
- Asia-Pacific is projected as the fastest-growing region, fueled by increasing healthcare investments and expanding biomedical research in countries like China and India. Growing awareness of personalized medicine and supportive government initiatives are significantly contributing to its rapid market expansion.
- In Europe, there's a noteworthy trend towards integrating automated biobanking solutions for enhanced sample management and data security. Collaborative research projects and a strong emphasis on standardized biobanking protocols across various countries are also shaping the regional market landscape.
Asia Pacific
8.1% CAGR
$1.2 Bn
42.1% share
- Dominates due to rapid expansion in healthcare infrastructure, increasing research funding, and a large population base driving demand for personalized medicine and disease diagnostics.
- Significant government initiatives and investments in genomics and biomedical research further propel market growth.
North America
5.5% CAGR
$826.5 Mn
28.5% share
- Holds a substantial share, driven by advanced research institutions, high adoption of cutting-edge biobanking technologies, and significant R&D spending in biotechnology and pharmaceutical sectors.
- The presence of key market players and robust regulatory frameworks also contribute to its stability.
Europe
5.9% CAGR
$559.7 Mn
19.3% share
- A strong market characterized by well-established research ecosystems, a growing number of biobanks, and increasing focus on personalized medicine and aging populations.
- Collaborative research initiatives and government support for biomedical sciences further stimulate demand for biobank equipment.
Latin America
7.2% CAGR
$159.5 Mn
5.5% share
- Experiencing steady growth as healthcare infrastructure improves and investments in medical research expand across the region.
- Increasing awareness of biobanking benefits for disease research and clinical trials is fostering market development, though from a relatively smaller base.
Middle East & Africa
7.5% CAGR
$92.8 Mn
3.2% share
- An emerging market showing promise with increasing healthcare expenditure, strategic government investments in biotechnology hubs, and a focus on addressing regional disease burdens.
- The development of new medical cities and research centers is driving demand for modern biobanking solutions.
Emerging Areas
8.5% CAGR
$40.6 Mn
1.4% share
- Represents nascent markets with early-stage development in healthcare and research infrastructure, presenting high growth potential from a low base.
- Initial investments, often supported by international aid or specific regional initiatives, are slowly establishing the foundation for future biobanking activities.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $739.5 Mn | 8.1% | The largest market, driven by extensive R&D, numerous biotech and pharmaceutical companies, and a high volume of clinical trials requiring robust biobanking infrastructure. |
| 2 | Brazil | $43.5 Mn | 10.5% | The largest market in Latin America, driven by a growing healthcare sector, increasing prevalence of chronic diseases, and expanding research initiatives in genomics and public health. |
| 3 | Germany | $182.7 Mn | 7.9% | A strong economy with advanced healthcare infrastructure, leading pharmaceutical companies, and significant investment in biomedical research and academic biobanks, fueling demand for high-end equipment. |
| 4 | China | $522.0 Mn | 11.5% | Rapid expansion of the life sciences sector, massive government investment in biotech and healthcare, and large population cohort studies are fueling immense demand for biobanking equipment. |
| 5 | Saudi Arabia | $26.1 Mn | 11.0% | Significant government investment in healthcare infrastructure and biomedical research as part of Vision 2030, driving the establishment of advanced biobanks and research centers. |
Countries Covered (24)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Switzerland, Italy, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Singapore, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | PHC Holdings Corporation | 5.7% | Focus on integrated solutions for life sciences and healthcare, leveraging advanced technology and a global presence. | They are a diversified healthcare company with a strong presence in laboratory equipment under their PHCbi brand. | Continuously innovating their PHCbi line of ultra-low freezers for enhanced energy efficiency and sample security. | PHCbi VIP ECO Series Ultra-low FreezersPHCbi MDF Series -86°C Upright FreezersPHCbi MPR Series Pharmaceutical Refrigerators+1 |
| 2 | Brooks Automation | 5.4% | Provide end-to-end automated solutions for sample management and cryopreservation across the entire cold chain, primarily through its Azenta Life Sciences brand. | They spun off their semiconductor business, focusing entirely on life sciences as Azenta Life Sciences, specializing in automated sample management. | Successfully transitioned and rebranded its life sciences tools and services business to Azenta Life Sciences, emphasizing its dedicated focus. | CryoPod CarrierBioStore III Cryopreservation SystemArktic -80°C Automated Stores+1 |
| 3 | Eppendorf | 5.1% | Offer high-quality, reliable, and user-friendly laboratory equipment and consumables, focusing on precision and reproducibility for research and clinical applications. | Renowned for high-quality pipettes and centrifuges, they also have a strong portfolio in freezers and incubators for biological sample management. | Expanded its product portfolio in bioprocess solutions and digital lab tools to meet evolving research and production needs. | CryoCube F740h -86°C Ultra-low Temperature FreezerInnova IncubatorsCentrifuges+1 |
| 4 | Haier Biomedical | 4.9% | Global expansion by offering cost-effective, high-performance biobanking solutions with a strong emphasis on smart technology and comprehensive cold chain integration. | A leading global provider of complete cold chain solutions for biomedical applications, with significant market share in developing regions and smart technology integration. | Continuously investing in IoT-enabled smart solutions for real-time monitoring and management of biomedical cold chain equipment. | DW-86L Series Ultra-low Temperature FreezersBPR Series Blood Bank RefrigeratorsIce-lined Refrigerators+1 |
| 5 | Helmer Scientific | 4.6% | Specialize in high-quality, medical-grade cold storage and processing equipment with a focus on reliability, performance, and exceptional customer service for critical healthcare applications. | Known for their medical-grade refrigeration and freezing equipment, particularly in blood banking, pharmacy, and clinical laboratory settings. | Introduced new energy-efficient models of their ultra-low freezers to meet sustainability goals and reduce operational costs in labs and healthcare facilities. | i.Series Ultra-low Freezersi.Series Blood Bank Refrigeratorsi.Series Plasma Freezers+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
PHC Holdings Corporation, Brooks Automation, Eppendorf, Haier Biomedical, Helmer Scientific, Chart Industries, B Medical Systems, BioLife Solutions, Custom Biogenic Systems, Arctiko, Angelantoni Life Science, Zhongke Meiling Cryogenics, Binder GmbH, Worthington Industries, Nihon Freezer Co., Ltd., Planer PLC, CryoSafe, Esco Lifesciences Group, REMI Group, ILC Dover
The global Biobank Equipment market features a competitive landscape led by PHC Holdings Corporation, Brooks Automation, Eppendorf, Haier Biomedical, Helmer Scientific, and Chart Industries, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
PHC Holdings Corporation
Brooks Automation
Eppendorf
Haier Biomedical
Helmer Scientific
Chart Industries
B Medical Systems
BioLife Solutions
Custom Biogenic Systems
Arctiko
Angelantoni Life Science
Zhongke Meiling Cryogenics
Binder GmbH
Worthington Industries
Nihon Freezer Co., Ltd.
Planer PLC
CryoSafe
Esco Lifesciences Group
REMI Group
ILC Dover
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Thermo Scientific Launches New Automated Cryogenic Biorepository System
Thermo Fisher Scientific introduced its advanced ArctiStream™ Automated Cryogenic Biorepository, featuring enhanced robotic sample handling and integrated software for high-throughput, secure biobanking operations. This launch aims to improve sample integrity and operational efficiency for large-scale biobanks.
Sartorius Acquires Bio-Automation Systems to Expand Cryo-Storage Portfolio
Sartorius AG announced the acquisition of Bio-Automation Systems, a specialist in automated sample processing and storage solutions for biological materials. This strategic move strengthens Sartorius's position in the rapidly growing market for automated biobanking equipment.
PHCbi Partners with LIMS Provider for Integrated Biobank Management Solutions
PHC Holdings Corporation (PHCbi) forged a partnership with LabLogic Systems, a leading LIMS provider, to offer seamless integration between PHCbi's ultra-low temperature freezers and LabLogic's sample management software. This collaboration seeks to streamline data management and compliance for modern biobanks.
CryoTech Innovations Secures $25M Investment for Novel Dry Cryogenic Storage Technology
Startup CryoTech Innovations completed a successful Series B funding round, raising $25 million to accelerate the development and commercialization of its innovative dry cryogenic storage platforms. This investment signals growing interest in more sustainable and energy-efficient alternatives to traditional liquid nitrogen storage.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $2.9 Bn |
| Market Size (Forecast) | $11.3 Bn |
| CAGR | 14.6% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 24 Countries |
| Segments Covered | 6 Segments, 44 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included